Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection.

BACKGROUND AND AIM The treatment efficacy of patients with mixed hepatitis C virus (HCV) genotype 1/genotype 2 (HCV-1/2) remains unknown. We aimed to elucidate the sustained virological response (SVR) rate in patients with HCV-1/2 infection. METHODS One hundred and ten HCV-1/2 patients treated with response-guided peginterferon/ribavirin therapy (24 weeks… CONTINUE READING